$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2019-10-17 | 59.59 | 59.53 | 59.62 | 59.52 | 285,608 |
2019-10-16 | 59.68 | 59.53 | 59.73 | 59.53 | 852,596 |
2019-10-15 | 59.72 | 59.70 | 59.73 | 59.68 | 355,183 |
2019-10-14 | 59.66 | 59.72 | 59.7459 | 59.65 | 272,984 |
2019-10-11 | 59.62 | 59.66 | 59.73 | 59.62 | 386,092 |
2019-10-10 | 59.58 | 59.58 | 59.63 | 59.55 | 381,874 |
2019-10-09 | 59.58 | 59.59 | 59.60 | 59.52 | 260,205 |
2019-10-08 | 59.57 | 59.53 | 59.62 | 59.51 | 503,618 |
2019-10-07 | 59.60 | 59.59 | 59.635 | 59.55 | 359,248 |
2019-10-04 | 59.58 | 59.63 | 59.72 | 59.55 | 226,942 |
2019-10-03 | 59.46 | 59.58 | 59.62 | 59.43 | 339,089 |
2019-10-02 | 59.55 | 59.46 | 59.60 | 59.38 | 532,825 |
2019-10-01 | 59.60 | 59.54 | 59.62 | 59.51 | 868,382 |
2019-09-30 | 59.65 | 59.50 | 59.67 | 59.49 | 639,183 |
2019-09-27 | 59.69 | 59.65 | 59.69 | 59.59 | 851,274 |
2019-09-26 | 59.67 | 59.61 | 59.75 | 59.58 | 194,356 |
2019-09-25 | 59.61 | 59.63 | 59.69 | 59.61 | 205,475 |
2019-09-24 | 59.63 | 59.60 | 59.69 | 59.59 | 353,508 |
2019-09-23 | 59.60 | 59.60 | 59.65 | 59.55 | 1,108,254 |
2019-09-20 | 59.65 | 59.66 | 59.82 | 59.63 | 329,591 |
News, Short Squeeze, Breakout and More Instantly...
EAST RUTHERFORD, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced it has completed an expansion of its biopharmaceutical analysis capabilities...
EAST RUTHERFORD, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Troy Player has been appointed as President, Early Stage Development an...
EAST RUTHERFORD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced changes to its management team and Board of Directors to accelera...